Stress ulcer prophylaxis in trauma patients

Jeffrey F. Barletta, Brian L Erstad, John B. Fortune

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Introduction. A number of issues concerning stress ulcer prophylaxis remain unresolved despite numerous randomized, controlled trials and several meta-analyses. The role of stress ulcer prophylaxis, particularly in trauma patients, is further complicated by the lack of trials utilizing clinically important bleeding as an endpoint. Given the lack of consensus regarding stress ulcer prophylaxis in trauma patients, prescribing practices at Level I trauma centers in the United States were assessed. Materials and methods. A survey was developed that contained questions related to institutional prescribing and evaluation of stress ulcer prophylaxis. The survey was intended to delineate these practices at the 188 Level I trauma centers (at the time of the present survey) in the United States. Results. One hundred and nineteen surveys were returned, yielding a response rate of 63%. Eighty-six percent stated that medications for stress ulcer prophylaxis are used in a vast majority of trauma patients admitted to the intensive care unit. Sixty-five percent stated that there is one preferred medication. For these institutions, histamine-2-blockers were the most popular at 71%. Thirty-nine percent stated that greater than 50% of patients remain on stress ulcer prophylaxis following discharge from the intensive care unit. Conclusion. The lack of consensus with regards to appropriate stress ulcer prophylaxis is apparent in this survey of Level I trauma centers. For those institutions with a preferred agent, histamine-2-blockers were most common.

Original languageEnglish (US)
Pages (from-to)526-530
Number of pages5
JournalCritical Care
Volume6
Issue number6
DOIs
StatePublished - Dec 2002

Fingerprint

Ulcer
Wounds and Injuries
Trauma Centers
Intensive Care Units
Histamine Agents
Histamine
Meta-Analysis
Randomized Controlled Trials
Surveys and Questionnaires
Hemorrhage

Keywords

  • Prophylaxis
  • Stress ulcers
  • Trauma

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Stress ulcer prophylaxis in trauma patients. / Barletta, Jeffrey F.; Erstad, Brian L; Fortune, John B.

In: Critical Care, Vol. 6, No. 6, 12.2002, p. 526-530.

Research output: Contribution to journalArticle

Barletta, JF, Erstad, BL & Fortune, JB 2002, 'Stress ulcer prophylaxis in trauma patients', Critical Care, vol. 6, no. 6, pp. 526-530. https://doi.org/10.1186/cc1831
Barletta, Jeffrey F. ; Erstad, Brian L ; Fortune, John B. / Stress ulcer prophylaxis in trauma patients. In: Critical Care. 2002 ; Vol. 6, No. 6. pp. 526-530.
@article{8d84c19de7884132a64193d4701ed54d,
title = "Stress ulcer prophylaxis in trauma patients",
abstract = "Introduction. A number of issues concerning stress ulcer prophylaxis remain unresolved despite numerous randomized, controlled trials and several meta-analyses. The role of stress ulcer prophylaxis, particularly in trauma patients, is further complicated by the lack of trials utilizing clinically important bleeding as an endpoint. Given the lack of consensus regarding stress ulcer prophylaxis in trauma patients, prescribing practices at Level I trauma centers in the United States were assessed. Materials and methods. A survey was developed that contained questions related to institutional prescribing and evaluation of stress ulcer prophylaxis. The survey was intended to delineate these practices at the 188 Level I trauma centers (at the time of the present survey) in the United States. Results. One hundred and nineteen surveys were returned, yielding a response rate of 63{\%}. Eighty-six percent stated that medications for stress ulcer prophylaxis are used in a vast majority of trauma patients admitted to the intensive care unit. Sixty-five percent stated that there is one preferred medication. For these institutions, histamine-2-blockers were the most popular at 71{\%}. Thirty-nine percent stated that greater than 50{\%} of patients remain on stress ulcer prophylaxis following discharge from the intensive care unit. Conclusion. The lack of consensus with regards to appropriate stress ulcer prophylaxis is apparent in this survey of Level I trauma centers. For those institutions with a preferred agent, histamine-2-blockers were most common.",
keywords = "Prophylaxis, Stress ulcers, Trauma",
author = "Barletta, {Jeffrey F.} and Erstad, {Brian L} and Fortune, {John B.}",
year = "2002",
month = "12",
doi = "10.1186/cc1831",
language = "English (US)",
volume = "6",
pages = "526--530",
journal = "Critical Care",
issn = "1364-8535",
publisher = "BioMed Central Ltd.",
number = "6",

}

TY - JOUR

T1 - Stress ulcer prophylaxis in trauma patients

AU - Barletta, Jeffrey F.

AU - Erstad, Brian L

AU - Fortune, John B.

PY - 2002/12

Y1 - 2002/12

N2 - Introduction. A number of issues concerning stress ulcer prophylaxis remain unresolved despite numerous randomized, controlled trials and several meta-analyses. The role of stress ulcer prophylaxis, particularly in trauma patients, is further complicated by the lack of trials utilizing clinically important bleeding as an endpoint. Given the lack of consensus regarding stress ulcer prophylaxis in trauma patients, prescribing practices at Level I trauma centers in the United States were assessed. Materials and methods. A survey was developed that contained questions related to institutional prescribing and evaluation of stress ulcer prophylaxis. The survey was intended to delineate these practices at the 188 Level I trauma centers (at the time of the present survey) in the United States. Results. One hundred and nineteen surveys were returned, yielding a response rate of 63%. Eighty-six percent stated that medications for stress ulcer prophylaxis are used in a vast majority of trauma patients admitted to the intensive care unit. Sixty-five percent stated that there is one preferred medication. For these institutions, histamine-2-blockers were the most popular at 71%. Thirty-nine percent stated that greater than 50% of patients remain on stress ulcer prophylaxis following discharge from the intensive care unit. Conclusion. The lack of consensus with regards to appropriate stress ulcer prophylaxis is apparent in this survey of Level I trauma centers. For those institutions with a preferred agent, histamine-2-blockers were most common.

AB - Introduction. A number of issues concerning stress ulcer prophylaxis remain unresolved despite numerous randomized, controlled trials and several meta-analyses. The role of stress ulcer prophylaxis, particularly in trauma patients, is further complicated by the lack of trials utilizing clinically important bleeding as an endpoint. Given the lack of consensus regarding stress ulcer prophylaxis in trauma patients, prescribing practices at Level I trauma centers in the United States were assessed. Materials and methods. A survey was developed that contained questions related to institutional prescribing and evaluation of stress ulcer prophylaxis. The survey was intended to delineate these practices at the 188 Level I trauma centers (at the time of the present survey) in the United States. Results. One hundred and nineteen surveys were returned, yielding a response rate of 63%. Eighty-six percent stated that medications for stress ulcer prophylaxis are used in a vast majority of trauma patients admitted to the intensive care unit. Sixty-five percent stated that there is one preferred medication. For these institutions, histamine-2-blockers were the most popular at 71%. Thirty-nine percent stated that greater than 50% of patients remain on stress ulcer prophylaxis following discharge from the intensive care unit. Conclusion. The lack of consensus with regards to appropriate stress ulcer prophylaxis is apparent in this survey of Level I trauma centers. For those institutions with a preferred agent, histamine-2-blockers were most common.

KW - Prophylaxis

KW - Stress ulcers

KW - Trauma

UR - http://www.scopus.com/inward/record.url?scp=0036892347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036892347&partnerID=8YFLogxK

U2 - 10.1186/cc1831

DO - 10.1186/cc1831

M3 - Article

C2 - 12493075

AN - SCOPUS:0036892347

VL - 6

SP - 526

EP - 530

JO - Critical Care

JF - Critical Care

SN - 1364-8535

IS - 6

ER -